Humana Inc (NYSE:HUM) SVP Brian P. Leclaire sold 1,679 shares of the stock in a transaction that occurred on Thursday, December 21st. The shares were sold at an average price of $245.97, for a total transaction of $412,983.63. Following the transaction, the senior vice president now owns 9,888 shares in the company, valued at $2,432,151.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Humana Inc (HUM) traded up $2.81 during trading hours on Friday, reaching $268.02. 1,573,430 shares of the company were exchanged, compared to its average volume of 1,016,461. Humana Inc has a 12 month low of $186.25 and a 12 month high of $271.99. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.61 and a quick ratio of 1.61. The stock has a market capitalization of $37,887.92, a PE ratio of 21.09, a price-to-earnings-growth ratio of 1.73 and a beta of 0.88.
Humana (NYSE:HUM) last posted its earnings results on Wednesday, November 8th. The insurance provider reported $3.39 EPS for the quarter, beating the Zacks’ consensus estimate of $3.27 by $0.12. The company had revenue of $13.28 billion during the quarter, compared to analysts’ expectations of $13.41 billion. Humana had a net margin of 3.49% and a return on equity of 15.99%. Humana’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.18 earnings per share. equities analysts anticipate that Humana Inc will post 11.63 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be issued a $0.40 dividend. The ex-dividend date is Thursday, December 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.60%. Humana’s dividend payout ratio is currently 12.59%.
Humana declared that its board has initiated a share buyback program on Thursday, December 14th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the insurance provider to buy shares of its stock through open market purchases. Shares repurchase programs are usually an indication that the company’s management believes its stock is undervalued.
A number of equities analysts have recently issued reports on HUM shares. Credit Suisse Group dropped their price objective on shares of Humana from $256.00 to $246.00 and set a “neutral” rating on the stock in a research note on Friday, November 10th. ValuEngine downgraded shares of Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. BMO Capital Markets started coverage on shares of Humana in a research note on Monday, October 16th. They set an “outperform” rating and a $300.00 price objective on the stock. Goldman Sachs Group started coverage on shares of Humana in a research note on Wednesday, January 3rd. They set a “buy” rating and a $305.00 price objective on the stock. Finally, Zacks Investment Research downgraded shares of Humana from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 17th. Ten research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $258.90.
Several hedge funds and other institutional investors have recently bought and sold shares of HUM. WFG Advisors LP raised its holdings in shares of Humana by 4.5% in the second quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock worth $113,000 after buying an additional 20 shares during the last quarter. Fieldpoint Private Securities LLC purchased a new position in shares of Humana in the third quarter worth $115,000. Acrospire Investment Management LLC purchased a new position in shares of Humana in the second quarter worth $120,000. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Humana by 139.5% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock worth $134,000 after buying an additional 325 shares during the last quarter. Finally, Fiduciary Trust Co. purchased a new position in shares of Humana in the second quarter worth $135,000. 94.01% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY NOTICE: This piece was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/01/13/humana-inc-hum-svp-brian-p-leclaire-sells-1679-shares.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.